Nufarm's Earnings at Risk From U.S.-China Tariff Blows -- Market Talk

Dow Jones
02-05

2331 GMT - Crop chemicals producer Nufarm's earnings likely aren't immune from tit-for-tat trade measures taken by the U.S. and China, contends Macquarie. The U.S. has imposed an additional 10% tariff on Chinese imports, prompting Beijing to respond. Macquarie highlights that 28% of Nufarm's earnings are from North America, and the company relies heavily on sourcing agricultural chemicals from China to sell into markets including the U.S. Nufarm's costs are likely to rise as the trade war unfolds. Still, Nufarm has some production in the U.S. and recently upgraded its manufacturing capacity in Australia so has "some ability to self-source," says Macquarie. It retains a neutral call on Nufarm. (david.winning@wsj.com; @dwinningWSJ)

 

(END) Dow Jones Newswires

February 04, 2025 18:31 ET (23:31 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10